Glioblastoma is an aggressive form of brain cancer, with only 5% of patients surviving more than five years after diagnosis. This is because the cancer often becomes resistant to treatment and recurs.
Repurposing cancer drugs to treat glioblastoma could offer new hope for glioblastoma patients, a joint study by researchers from NTU's Lee Kong Chian School of Medicine and the National Neuroscience Institute has found.
The scientists found that the drugs inhibited two signalling pathways in glioblastoma cells associated with cancer growth and spread, restoring effectiveness of glioblastoma treatment.
The findings pave the way for more effective and precise therapies for the deadly disease.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
